Cited by 254Acute Myocardial Infarction ResearchPlatelet Disorders and TreatmentsAntiplatelet Therapy and Cardiovascular Diseases

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Platelet Function Predicts Myocardial Damage in Patients With Acute Myocardial Infarction

Frossard, Martin, Fuchs, Ingrid, Leitner, Judith M., Hsieh, Kety, Vlcek, Marianne, Losert, Heidrun, Domanovits, Hans, Schreiber, Wolfgang, Laggner, Anton N., Jilma, Bernd·2004·Circulation

DOI 10.1161/01.cir.0000141575.92958.9c

Open this paper in CoChat — free account

Abstract

Background— Platelet activation is a hallmark of acute coronary syndromes. Numerous lines of evidence suggest a mechanistic link between von Willebrand factor or platelet hyperfunction and myocardial damage in patients with acute coronary syndromes. Thus, we assessed whether platelet function under high shear rates (collagen adenosine diphosphate closure times [CADP-CTs]) measured with the platelet function analyzer (PFA-100) may be enhanced in patients with myocardial infarction (MI) and whether it may predict the extent of myocardial damage as measured by creatine kinase (CK-MB) or troponin T (TnT) levels. Methods and Results— Patients with acute chest pain or symptoms suggestive of acute coronary syndromes (n=216) were prospectively examined at an emergency department. CADP-CT was significantly shorter in patients with MI, particularly in those with an ST-segment-elevation MI (STEMI) compared with the other patient groups (unstable angina, stable coronary artery disease, or controls). Furthermore, CADP-CT and collagen epinephrine–CT at presentation were independent predictors of myocardial damage as measured by CK-MB or TnT. Patients with MI whose CADP-CT values fell in the first quartile had 3-fold higher CK-MB and TnT levels than those in the fourth quartile. Conclusions— Patients with STEMI have significantly enhanced platelet function when measured under high shear rates. CADP-CT is an independent predictor of the severity of MI, as measured by markers of cardiac necrosis. Measurement of platelet function with the PFA-100 may help in the risk stratification of patients presenting with MI.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000141575.92958.9c

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary
Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E., Green, L. A., Hand, M. M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., Lamas, G. A., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,348
Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction
Antman, E. M., Bassand, J., Klein, W. W., Ohman, M. E., Sendón, J. L. L., Rydén, L., Simoons, M. L., & Tendera, M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00804-4 · Cited by 4,824
ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D. J., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,475
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
Thompson, S. G., Kienast, J., Pyke, S., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,819
Prognostic Value of Myeloperoxidase in Patients with Chest Pain
Brennan, M., Penn, M. S., Lente, F. V., Nambi, V., Shishehbor, M. H., Aviles, R. J., Goormastic, M., Pepoy, M. L., McErlean, E. S., Topol, E. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035003 · Cited by 1,071
ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction—2002: Summary Article
D, E. B. M., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D. J., Kupersmith, J., Levin, T. N., et al. (2002) · Circulation · doi:10.1161/01.cir.0000037106.76139.53 · Cited by 844
1999 Update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations
Ryan, T. J., Antman, E. M., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., Riegel, B. J., Russell, R. O., Smith, E. E., et al. (1999) · Circulation · doi:10.1161/01.cir.100.9.1016 · Cited by 742
Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina
Aukrust, P., Müller, F., Ueland, T., Berget, T., Aaser, E., Brunsvig, A., Solum, N. O., Forfang, K., Frøland, S. S., & Gullestad, L. L. (1999) · Circulation · doi:10.1161/01.cir.100.6.614 · Cited by 506
von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?
Lip, G. Y. H. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00039-4 · Cited by 457
Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes
Roffi, M., Chew, D. P., Mukherjee, D., Bhatt, D. L., White, J. A., Heeschen, C., Hamm, C. W., Moliterno, D. J., Califf, R. M., White, H. D., et al. (2001) · Circulation · doi:10.1161/hc4801.100029 · Cited by 427

Show all 36 references

Research works printed but not linked: 12

10.1161/circ.100.6.614 · DOI
10.1161/circ.94.6.1239 · DOI
10.1161/circ.100.20.2045 · DOI
10.1161/circ.104.23.2767 · DOI
10.1182/blood.V65.4.823.823 · DOI
10.1161/circ.99.5.608 · DOI
10.1161/circ.100.9.1016 · DOI
2000, Br J Haematol, 111, 733
10.1161/circ.102.19.2329 · DOI
10.1161/circ.101.13.1619 · DOI
2003, J Thromb Haemost, 1, OC328.
2002, Rev Cardiovasc Med, 3, S13

Sorted by citations

Items 101–200 of 253

Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery disease
Bernardo, E., Angiolillo, D. J., Ramírez, C., Cavallari, U., Trabetti, E., Sabaté, M., Hernández, R., Moreno, R., Escaned, J., Alfonso, F., et al. (2006) · Platelets · doi:10.1080/09537100600881412 · Cited by 25
A contemporary viewpoint on ‘aspirin resistance’
Kuzniatsova, N., Shantsila, E., Blann, A. D., & Lip, G. Y. H. (2012) · Annals of Medicine · doi:10.3109/07853890.2011.605388 · Cited by 25
Mean Platelet Volume Associated With Aortic Distensibility, Chronic Inflammation, and Diabetes in Patients With Stable Coronary Artery Disease
Şahin, D. Y., Gür, M., Elbasan, Z., Yıldırım, A., Akıllı, R. E., Koyunsever, N. Y., Özaltun, B., Gözübüyük, G., Kıvrak, A., & Çaylı, M. (2012) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612468941 · Cited by 24
Antiplatelet effect of aspirin in patients with coronary artery disease.
Grove, E. L. (2012) · PubMed · Cited by 24
Clinical Tests of Platelet Function
Harrison, P., & Lordkipanidzé, M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387837-3.00026-2 · Cited by 24
Disposable electrochemical immunosensor for myeloperoxidase based on the indium tin oxide electrode modified with an ionic liquid composite film containing gold nanoparticles, poly(o-phenylenediamine) and carbon nanotubes
Liu, B., Lu, L., Li, Q., & Xie, G. (2011) · Microchimica Acta · doi:10.1007/s00604-011-0575-6 · Cited by 23
Persistent platelet activation is related to very early cardiovascular events in patients with acute coronary syndromes.
Małek, Ł. A., Śpiewak, M., Filipiak, K. J., Grabowski, M., Szpotanska‐Sikorska, M., Rosiak, M., Główczyńska, R., Imiela, T., Huczek, Z., & Opolski, G. (2007) · PubMed · Cited by 22
Combination of White Blood Cell Count to Mean Platelet Volume Ratio and Neutrophil-to-Platelet Ratio Predicts Long-Term Adverse Events in Patients with MINOCA
Mohammed, A. A. S., Liu, L., Mareai, R. M., Mohammed, A., Yin, G., Singh, S., Xu, Y., Abdu, F. A., & Che, W. (2022) · Mediators of Inflammation · doi:10.1155/2022/5642406 · Cited by 21
von Willebrand Factor and Oxidative Stress Parameters in Acute Coronary Syndromes
Koprivica, Z., Djordjevic, D. Z., Vuletic, M., Zivkovic, V. I., Barudzic, N. S., Andjelkovic, N. V., Djuric, D. M., Iric-Cupic, V., Krkeljić, J., & Jakovljevic, V. L. (2011) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2011/918312 · Cited by 20
Value of Routine Admission Laboratory Tests to Predict Thirty-Day Mortality in Patients With Acute Myocardial Infarction
Sjauw, K. D., van der Horst, I. C. C., Nijsten, M. W. N., Nieuwland, W., & Zijlstra, F. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.034 · Cited by 20
P2Y12 inhibitors adjunctive to primary PCI therapy in STEMI: Fighting against the activated platelets
Alexopoulos, D. K. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.11.088 · Cited by 19
Platelet hyperfunction is decreased by additional aspirin loading in patients presenting with myocardial infarction on daily aspirin therapy
Fuchs, I., Spiel, A. O., Frossard, M., Derhaschnig, U., Riedmüller, E., & Jilma, B. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181de8b1e · Cited by 20
Self-citation
The in vitro effect of the new antithrombotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary intervention
van Loon, J. E., de Jaegere, P. P. T., van Vliet, H. H. D. M., de Maat, M. P. M., de Groot, P. G., Simoons, M. L., & Leebeek, F. W. G. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-12-0804 · Cited by 20
Platelet function testing in cardiovascular diseases
Michelson, A. D. (2005) · Hematology · doi:10.1080/10245330512331390186 · Cited by 20
Monitoring Antiplatelet Therapy with Point-of-Care Platelet Function Assays: A Review of the Evidence
van Werkum, J. W., Hackeng, C. M., Smit, J. J. J., Hof, A. W. J. V. ’., Verheugt, F. W. A., & ten Berg, J. M. (2007) · Future Cardiology · doi:10.2217/14796678.4.1.33 · Cited by 20
Identification of potential biomarkers and immune cell infiltration in acute myocardial infarction (AMI) using bioinformatics strategy
Xie, Y., Wáng, Y., Zhao, L., Wang, F., & Fang, J. (2021) · Bioengineered · doi:10.1080/21655979.2021.1937906 · Cited by 19
Pro-Inflammatory Food, Gut Microbiota, and Cardiovascular and Pancreatic Diseases
Chen, B., Patel, S., Bao, L., Nadeem, D., & Krittanawong, C. (2024) · Biomolecules · doi:10.3390/biom14020210 · Cited by 18
Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients
Falcinelli, E., Francisci, D., Schiaroli, E., Minuz, P., Orsini, S. I., Malincarne, L., Sebastiano, M., Mezzasoma, A. M., Pasticci, M. B., Guglielmini, G., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.04.052 · Cited by 19
Evaluation of platelet function in aspirin treated patients with CAD
Williams, M. S., Kickler, T. S., Vaidya, D. M., Ng’alla, L. S., & Bush, D. E. (2006) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-006-6968-4 · Cited by 19
The relationship between platelet reactivity and infarct-related artery patency in patients presenting with a ST-elevation myocardial infarction
Breet, N. J., van Werkum, J. W., Bouman, H. J., Kelder, J. C., Hackeng, C. M., & ten Berg, J. M. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-08-0528 · Cited by 19
Platelet activation and cardiovascular outcomes in acute coronary syndromes
Boos, C. J., & Lip, G. Y. H. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02250.x · Cited by 19
Platelet deposition in remote cardiac regions after coronary occlusion
Barrabés, J. A., Mirabet, M., Agulló, L., Figueras, J., Pizcueta, P. M., & David Garcia-dorado, A. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01883.x · Cited by 19
Pharmacokinetics and Pharmacodynamics of the Dual FII/FX Inhibitor BIBT 986 in Endotoxin-induced Coagulation
Leitner, J. M., Jilma, B., Mayr, F., Cardona, F., Spiel, A. O., Firbas, C., Rathgen, K., Stähle, H., Schühly, U., & Graefe-Mody, E. U. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100153 · Cited by 19
Self-citation
Resistance to aspirin and clopidogrel therapy
Musallam, K. M., Charafeddine, K. M., Bitar, A., Khoury, M., Assaad, S., Beresian, J., Alam, S., & Taher, A. T. (2010) · International Journal of Laboratory Hematology · doi:10.1111/j.1751-553x.2010.01268.x · Cited by 18
Antiplatelet Effect of Thienopyridine (Clopidogrel or Prasugrel) Pretreatment in Patients Undergoing Primary Percutaneous Intervention for ST Elevation Myocardial Infarction
Beigel, R., Fefer, P., Rosenberg, N., Novikov, I., Elian, D., Fink, N., Segev, A., Guetta, V., Hod, H., & Matetzky, S. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.07.010 · Cited by 18
Single dose granulocyte colony-stimulating factor markedly enhances shear-dependent platelet function in humans
Spiel, A. O., Siller-Matula, J. M., Firbas, C., Leitner, J. M., Russmueller, G., & Jilma, B. (2010) · Platelets · doi:10.3109/09537104.2010.485255 · Cited by 18
Self-citation
Promotion of proinflammatory interactions between platelets and monocytes by unfractionated heparin
Harding, S. A., Din, J. N., Sarma, J., Josephs, D. H., Fox, K. A. A., & Newby, D. E. (2006) · Heart · doi:10.1136/hrt.2005.063917 · Cited by 18
The Platelet Function Analyzer (PFA)-100
Francis, J. L. (2007) · Elsevier eBooks · doi:10.1016/b978-012369367-9/50790-4 · Cited by 18
Plasma levels of the growth arrest‐specific gene 6 product (Gas6) and antiplatelet drug responsiveness in healthy subjects
Burnier, L., Borgel, D., Angelillo‐Scherrer, A., & Fontana, P. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02155.x · Cited by 18
Von Willebrand factor antigen levels predict major adverse cardiovascular events in patients with carotid stenosis of the ICARAS study
Kovacevic, K. D., Mayer, F. J., Jilma, B., Buchtele, N., Obermayer, G., Binder, C. J., Blann, A. D., Minar, E., Schillinger, M., & Hoke, M. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.09.003 · Cited by 17
Self-citation
Preoperative platelet dysfunction predicts blood product transfusion in children undergoing cardiac surgery
Zubair, M. M., Bailly, D. K., Lantz, G., Sunstrom, R. E., Saharan, S., Boshkov, L. K., Sochacki, P., Hohimer, A. R., Lasarev, M. R., & Langley, S. M. (2014) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivu315 · Cited by 17
Mean platelet volume is associated with poor postinterventional myocardial blush grade in patients with ST-segment elevation myocardial infarction
Şarlı, B., Baktır, A. O., Sağlam, H., Arınç, H., Kurtul, S., Şıvgın, S., Akpek, M., & Kaya, M. G. (2013) · Coronary Artery Disease · doi:10.1097/mca.0b013e328360eff6 · Cited by 16
Platelet Function Testing in Patients with Acute Ischemic Stroke: An Observational Study
Rosafio, F., Lelli, N., Mimmi, S., Vandelli, L., Bigliardi, G., Dell’Acqua, M. L., Picchetto, L., Pentore, R., Ferraro, D., Trenti, T., et al. (2017) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2017.04.023 · Cited by 16
Platelet hyperactivity and risk of recurrent thrombosis
Harrison, P., & Keeling, D. M. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02249.x · Cited by 16
Adipsin deficiency does not impact atherosclerosis development in Ldlr −/− mice
Liu, L., Chan, M., Yu, L., Wang, W., & Qiang, L. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00440.2020 · Cited by 16
Coagulation parameters and platelet function analysis in patients with acromegaly
Çolak, A., Yılmaz, H., Temel, Y., Demirpençe, M., Şimşek, N., Karademirci, I., Bozkurt, Ü., & Yaşar, E. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0300-0 · Cited by 16
Relationships Among Gut Microbiota, Ischemic Stroke and Its Risk Factors: Based on Research Evidence
Huang, Q., Cai, G., Liu, T., & Liu, Z. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s353276 · Cited by 15
COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trial
Vlachojannis, G. J., Vogel, R. F., Wilschut, J., Lemmert, M. E., Delewi, R., Diletti, R., van Vliet, R., van der Waarden, N. W. P. L., Nuis, R.-J. M., Paradies, V., et al. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.03.005 · Cited by 15
Ischemic and Bleeding Events Associated with Thrombocytopenia and Thrombocytosis after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction
Roh, J. W., Lim, S., Hwang, Y., Lee, K. Y., Choo, E. H., Choi, I. J., Hwang, B., Kim, C. J., Park, M., Kim, D., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103370 · Cited by 15
Sex-based differences in clinical and angiographic outcomes in patients with ST-elevation myocardial infarction treated with concomitant use of glycoprotein IIb/IIIa inhibitors.
Kralev, S., Hennig, O., Lang, S., Kälsch, T., Borggrefe, M. M., Dempfle, C.-E. H., & Süselbeck, T. (2010) · PubMed · Cited by 15
Residual platelet reactivity after aspirin and clopidogrel treatment predicts 2-year major cardiovascular events in patients undergoing percutaneous coronary intervention
Chiu, F., Wang, T., Lee, J., Shih, F., Lin, J., Huang, C., Chen, W., & Chen, M.-F. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.02.021 · Cited by 15
Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
Mokhtar, O. A., Paganelli, F. F., Benamara, S., Azaza, A., Bonello, L., Hamza, O., Seddiki, S., Benathmane, T., Saidane, M., Bouzid, A., et al. (2017) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2016.12.017 · Cited by 15
Whole blood flow cytometry protocol for the assessment of platelet phenotype, function, and cellular interactions
Yaw, H. P., Helm, S. V. D., Linden, M. D., Monagle, P., & Ignjatović, V. (2020) · Platelets · doi:10.1080/09537104.2020.1810222 · Cited by 15
Effects of recombinant human erythropoietin on antiplatelet action of aspirin and clopidogrel in healthy subjects: Results of a double-blind, placebo-controlled randomized trial
Tang, Y.-D., Rinder, H. M., & Katz, S. D. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.06.036 · Cited by 14
Clinical Tests of Platelet Function
Harrison, P., & Keeling, D. M. (2007) · Elsevier eBooks · doi:10.1016/b978-012369367-9/50785-0 · Cited by 15
Effect of Hematologic Parameters on Microvascular Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
Karahan, Z., Uçaman, B., Uluğ, A. V., Aydınalp, Ö., Uğurlu, M., Çevik, K., Kaya, İ., & Öztürk, Ö. (2015) · Angiology · doi:10.1177/0003319715583204 · Cited by 14
The role of SCUBE1 in the pathogenesis of no-reflow phenomenon presenting with ST segment elevation myocardial infarction
Bolayır, H. A. (2017) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2017.7705 · Cited by 14
Intrinsic platelet reactivity and thrombus burden in patients with ST-elevation myocardial infarction
Alexopoulos, D. K., Xanthopoulou, I., Tsigkas, G., Δαμέλου, Α., Theodoropoulos, K. C., Makris, G., Gizas, V., Kassimis, G., Davlouros, P. A., & Hahalis, G. N. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.02.010 · Cited by 14
Antiplatelet Activity During Coadministration of the Selective Serotonin Reuptake Inhibitor Paroxetine and Aspirin in Male Smokers: A Randomized, Placebo‐Controlled, Double‐blind Trial
Kotzailias, N., Andonovski, T., Dukic, A., Serebruany, V. L., & Jilma, B. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006286432 · Cited by 14
Self-citation
The role of oxidative stress and inflammation in the early evaluation of acute non-ST-elevation myocardial infarction: an observational study
Gökdemir, M. T., Kaya, H., Söğüt, Ö., Kaya, Z., Albayrak, L., & Taşkın, A. (2012) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2013.037 · Cited by 13
Platelet biology: the role of shear
Wong, A. (2013) · Expert Review of Hematology · doi:10.1586/ehm.13.5 · Cited by 13
Abnormal PFA-100 closure time is associated with increased platelet aggregation in patients presenting with chest pain
Atiemo, A. D., Ng’alla, L. S., Vaidya, D. M., & Williams, M. S. (2007) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-007-0045-5 · Cited by 13
Functional Foods in Preventing Human Blood Platelet Hyperactivity-Mediated Diseases—An Updated Review
Duttaroy, A. K. (2024) · Nutrients · doi:10.3390/nu16213717 · Cited by 14
Clinical and laboratory factors associated with shear-dependent platelet hyper-reactivity in patients on chronic aspirin therapy
Nazarian, S. M., Thompson, J. B., Gluckman, T. J., Laws, K., Jani, J. T., Kickler, T. S., & Rade, J. J. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2009.04.016 · Cited by 12
Cross validation of aspirin effect in healthy individuals by Impact-R and PFA-100: A double blind randomized placebo controlled trial
Gouya, G., Jilma, B., Niel, M., Eichelberger, B., Wolzt, M., & Panzer, S. (2009) · Platelets · doi:10.1080/09537100902745117 · Cited by 12
Self-citation
Aspirin Resistance: Disparities and Clinical Implications
Airee, A., Draper, H. M., & Finks, S. W. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.8.999 · Cited by 12
Platelets and new antiplatelet drugs
Reiter, R. A., & Jilma, B. (2005) · Therapy · doi:10.1586/14750708.2.3.465 · Cited by 12
Self-citation
Current developments in anti-platelet therapy
Mayr, F., & Jilma, B. (2006) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-006-0330-5 · Cited by 12
Self-citation
Thyroid hormones and platelet activation in COVID-19 patients
Colonnello, E., Criniti, A., Lorusso, E., Curreli, M., Santulli, M., Angeloni, A., Gnessi, L., Gandini, O., & Lubrano, C. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01896-2 · Cited by 11
Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients
Zufferey, A., Reny, J., Combescure, C., de Moerloose, P., Sanchez, J., & Fontana, P. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-04-0226 · Cited by 11
Testing aspirin resistance using the platelet function analyzer-100: some methodological caveats and considerations
Madsen, E. H., Schmidt, E. B., GEHR, N., JOHANNESEN, N. L., & Kristensen, S. R. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02850.x · Cited by 11
Changes in platelet maturity and reactivity following acute ST-segment elevation myocardial infarction
Pedersen, O. B., Nissen, P. H., Pasalic, L., Hvas, A., Kristensen, S. D., & Grove, E. L. (2024) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2024.102652 · Cited by 10
Association of oral but not transdermal estrogen therapy with enhanced platelet reactivity in a subset of postmenopausal women
Flaumenhaft, R. C., Nachtigall, M. J., Lowenstein, J., Nachtigall, L. B., Nachtigall, R. H., & Nachtigall, L. E. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181833886 · Cited by 10
Association Between Level of Platelet Inhibition After Early Use of Abciximab and Myocardial Reperfusion in ST-Elevation Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention
de Prado, A. P., Fernández‐Vázquez, F., Cuellas-Ramón, J. C., Orcajo, N. A., de Blas, R. C., Pascual, C., Olalla, C., Diego‐Nieto, A., de Miguel, A., & Calabozo, R. G. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.10.019 · Cited by 10
Aspirin resistance determined from a bed-side test in patients suspected to have acute coronary syndrome portends a worse 6 months outcome
Chu, J. W., Wong, C. K., Chambers, J. A. A., Wout, J. V., Herbison, P., & Tang, E. W. (2010) · QJM · doi:10.1093/qjmed/hcq038 · Cited by 10
The investigation of biomarkers in cardiovascular disease: time for a coordinated, international effort
Becker, R. C. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi125 · Cited by 10
Impact of Nonadherence to Any Antiplatelet Therapy After PCI With Drug-Eluting Stents on Critical Outcomes
Mori, Y., Friede, T., Hattori, S., Yamaji, K., & Fukuma, S. (2025) · JACC Asia · doi:10.1016/j.jacasi.2025.03.008 · Cited by 9
Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke
Tobin, W. O., Kinsella, J. A., Kavanagh, G. F., O’Donnell, J. S., McGrath, R. T., Coughlan, T., Collins, R., O’Neill, D. J., Egan, B. M., Tierney, S., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7362-3 · Cited by 9
Platelets as Modifiers of Clinical Phenotype in Hemophilia
Yee, D. L. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.133 · Cited by 9
Platelet Content from Acute Myocardial Infarction Patients: Elevated Levels of IL-6 and IL-8 and their impact on Endothelial Nitric Oxide Production
Arauna, D., Chandia, E., Nova‐Lamperti, E., Radojkovic, C., Eduardo Fuentes, Q., Palomo, I. F., Guzmán‐Gutiérrez, E., Moore‐Carrasco, R., & Aguayo, C. R. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119119 · Cited by 8
Shexiang Baoxin Pill enriches Lactobacillus to regulate purine metabolism in patients with stable coronary artery disease
Wu, G., Liao, J., Zhu, X., Zhang, Y., Lin, Y., Zeng, Y., Zhao, J., Zhang, J., Yao, T., Shen, X., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155727 · Cited by 8
The clinical importance of laboratory-defined aspirin resistance in patients presenting with non-ST elevation acute coronary syndromes
Açıkel, S., Yı́ldı́rı́r, A., Aydınalp, A., Bal, U. A., Kaynar, G., Özin, B., & Müderrisoğlu, H. (2009) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32832c87b3 · Cited by 8
Lower tissue factor inhibition in patients with ST segment elevation than in patients with non ST elevation acute myocardial infarction
Figueras, J., Monasterio, J., Lidón, R. M., Sambola, A., & García‐Dorado, D. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.02.044 · Cited by 8
Platelet response to standard aspirin and clopidogrel treatment correlates with long-term outcome in patients with acute ST-elevation myocardial infarction
Miličić, D., Lovrić, D., Škorić, B., Skorić, K. N., Gornik, I., & Sertić, J. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.09.055 · Cited by 7
Point-of-care assessment of platelet reactivity in the emergency department may facilitate rapid rule-out of acute coronary syndromes: a prospective cohort pilot feasibility study
Darling, C. E., Mercado, J. A. S., Quiroga-Castro, W., Tecco, G. F., Zelaya, F., Conci, E., Sala, J., Smith, C. S., Michelson, A. D., Whittaker, P., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-003883 · Cited by 9
Duration of effects of aspirin on platelet function in healthy volunteers: an analysis using the PFA-100
Konrad, C. J., Schuepfer, G., Gerber, H., Rukwied, R., Schmelz, M., & Schley, M. T. (2006) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2005.05.007 · Cited by 8
Platelet microaggregation inhibition in patients with acute myocardial infarction pretreated with tirofiban and relationship with angiographic and clinical outcome
Smit, J. J. J., Ernst, N. M. S. K. J., Slingerland, R. J., Kolkman, J. J. E., Suryapranata, H., Hoorntje, J. C. A., Dambrink, J. H. E., Ottervanger, J. P., Gosselink, A. T. M., de Boer, M. J., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.05.025 · Cited by 8
Antiplatelet Drug Resistance: Not Ready for Prime Time
Burns, T. L., Mooss, A. N., & Hilleman, D. E. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.11.1621 · Cited by 8
Safety evaluation of tirofiban
Valgimigli, M., & Tebaldi, M. (2010) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2010.507189 · Cited by 7
Monitoring anticoagulation of primary haemostasis
Calatzis, A., Leitner, M., & Panzer, S. (2009) · Hämostaseologie · doi:10.1055/s-0037-1617037 · Cited by 7
Effect of exercise on platelet activation during aspirin or clopidogrel intake in healthy men
Madsen, E. H., Christiansen, M. K., Schmidt, E. B., Poulsen, T. S., & Kristensen, S. R. (2009) · Platelets · doi:10.1080/09537100902795484 · Cited by 7
Balancing potency of platelet inhibition with bleeding risk in the early treatment of acute coronary syndrome.
Slattery, D. E., & Pollack, C. V. (2009) · PubMed Central · Cited by 7
Serum trimethylamine N-oxide levels among coronary artery disease and acute coronary syndrome patients: a systematic review and meta-analysis
Dean, Y. E., Rouzan, S. S., Pintado, J. J. L., Talat, N. E., Mohamed, A. R. H., Verma, S., Kamdi, Z. A., Gir, D., Helmy, A., Helmy, Z., et al. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001426 · Cited by 7
P2 purinergic receptors at the heart of pathological left ventricular remodeling following acute myocardial infarction
Silva, A. V. V. D., Chesseron, S., Benouna, O., Rollin, J., Roger, S., Bourguignon, T., Chadet, S., & Ivanés, F. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00599.2024 · Cited by 7
Mean Platelet Volume and Platelet Function Analysis in Acromegalic Patients Before and after Treatment
Demirpençe, M. (2016) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2016.401 · Cited by 6
Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCI
Vogel, R. F., Delewi, R., Badimón, L., Angiolillo, D. J., & Vlachojannis, G. J. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2309297 · Cited by 8
Interplay of platelet polymorphisms, risk factors, and Von Willebrand factor, and flow-mediated conditions in determining collagen–adenosine diphosphate PFA-100 results in patients with coronary artery disease
Porto, I., Leone, A. M., Nanni, L., Sciahbasi, A., Vita, M. D., Lanza, G. A., & Andreotti, F. (2005) · Blood Coagulation & Fibrinolysis · doi:10.1097/01.mbc.0000161562.28646.94 · Cited by 6
Platelet reactivity and the identification of acute coronary syndromes in the emergency department
Darling, C. E., Michelson, A. D., Volturo, G., & Przyklenk, K. (2008) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-008-0242-x · Cited by 5
Clinical Significance of Laboratory-determined Aspirin Poor Responsiveness After Primary Percutaneous Coronary Intervention
Mrdović, I., Čolić, M., Savić, L., Krljanać, G., Kružliak, P., Lasica, R., Ašanin, M., Stankovic, S. D., & Marinković, J. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6643-8 · Cited by 5
Aspirin resistance: Prevalence and clinical outcome in Egypt
Salah, A., El-Desuky, M., Rizk, A., & Elhadidy, A. E. (2015) · The Egyptian Journal of Critical Care Medicine · doi:10.1016/j.ejccm.2014.12.001 · Cited by 5
Mean Platelet Volume as an early predictor for the complication of COVID-19
Sertbaş, Y. (2021) · Haydarpasa Numune Training and Research Hospital Medical Journal · doi:10.14744/hnhj.2020.90582 · Cited by 5
Platelet function (measured by Platelet Function Analyser ‐ 100) and obstructive sleep apnoea
West, S. D., Segal, H. C., Harrison, P., & Stradling, J. R. (2005) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2005.00469.x · Cited by 5
Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study
Mangiacapra, F., Patti, G., Barbato, E., Orlic, D. N., Peace, A. J., D’Ambrosio, A., Ostojić, M., Wijns, W. C., & Sciascio, G. D. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.06.015 · Cited by 5
Iron‐induced platelet aggregation measurement: a novel method to measure platelet function in stenting for ST segment elevation myocardial infarction
Smit, J. J. J., van Oeveren, W., Ottervanger, J. P., Slingerland, R. J., Remijn, J. A., Zijlstra, F., & Hof, A. W. J. V. ’. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02069.x · Cited by 5
The Molecular Human – A Roadmap of Molecular Interactions Linking Multiomics Networks with Disease EndpointsPreprint
Halama, A., Zaghlool, S. B., Thareja, G., Kader, S. A., Muftha, W. A., Mook-Kanamori, M. J., Sarwath, H., Mohamoud, Y. A., Ameling, S., Pučić‐Baković, M., et al. (2022) · medRxiv · doi:10.1101/2022.10.31.22281758 · Cited by 5
Proteomic analysis reveals activation of platelet- and fibrosis-related pathways in hearts of ApoE−/− mice exposed to diesel exhaust particles
Jung, I., Cho, Y. J., Park, M., Park, K., Lee, S. H., Kim, W., Jeong, H., Lee, J. E., & Kim, G. (2023) · Scientific Reports · doi:10.1038/s41598-023-49790-y · Cited by 4
Elevated Leukocyte Count and Platelet-Derived Thrombogenicity Measured Using the Total Thrombus-Formation Analysis System in Patients with ST-Segment Elevation Myocardial Infarction
Kikuchi, S., Tsukahara, K., Ichikawa, S., Abe, T., Nakahashi, H., Minamimoto, Y., Kimura, Y., Akiyama, E., Okada, K., Matsuzawa, Y., et al. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.64395 · Cited by 4
Associations between platelet indices and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: the CABLE study
Xiong, S.-Y., Zhao, Y., Fu, Y., Li, Q., Hao, Q., Zhang, D., Liu, M., Yin, S., Wang, L.-Y., Wang, Y.-C., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01755-1 · Cited by 4
A High-Throughput Biotin-Avidin-ELISA for Studying Expression of Platelet Membrane Glycoproteins and Its Clinical Application
Zhang, Y., Zhao, Y., Lu, S., Zhu, M., He, Y., & Ruan, C. (2010) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.222.83 · Cited by 4
The influence of citrate concentrations on PFA-100 closure times, platelet hyper-reactivity and aspirin monitoring
Harrison, P. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2009.11.001 · Cited by 4

Authors: Frossard, M., Fuchs, I., Leitner, J. M., Hsieh, K., Vlcek, M., Losert, H., Domanovits, H., Schreiber, W., Laggner, A. N., & Jilma, B.
Affiliations: University of Vienna (AT)
ORCID: Leitner, Judith M.
Hsieh, Kety
Losert, Heidrun
Domanovits, Hans
Schreiber, Wolfgang
Jilma, Bernd
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-09-14
Volume: 110
Issue: 11
Pages: 1392-1397
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.0000141575.92958.9c
OpenAlex: W2156637699
Cited by: 254
References: 36
Citations by year: 2026: 2 · 2025: 5 · 2024: 10 · 2023: 6 · 2022: 5 · 2021: 9 · 2020: 10 · 2019: 7 · 2018: 3 · 2017: 6 · 2016: 8 · 2015: 7 · 2014: 6 · 2013: 10 · 2012: 19
FWCI: 13.10
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
Keywords: platelet function, acute myocardial infarction, ST-elevation myocardial infarction, platelet function analyzer, high shear rate, von Willebrand factor, platelet hyperreactivity, myocardial injury, creatine kinase-MB, troponin T, risk stratification, acute coronary syndrome
MeSH terms: Clopidogrel, Abciximab, Tirofiban, Eptifibatide, Adenosine Diphosphate, Aged, Antibodies, Monoclonal, Anticoagulants, Aspirin, Cardiovascular Agents, Collagen, Female, Humans, Immunoglobulin Fab Fragments, Leukocyte Count, Male, Middle Aged, Myocardial Infarction, Myocardium, Necrosis, Peptides, Platelet Aggregation Inhibitors, Platelet Function Tests, Predictive Value of Tests, Prospective Studies, Ticlopidine, Tyrosine, von Willebrand Factor, Platelet Activation, Comorbidity, Myocardial Ischemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Platelet Function Predicts Myocardial Damage in Patients With Acute Myocardial Infarction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks